ATM mutations in B-cell chronic lymphocytic leukemia

被引:1
|
作者
Lähdesmäki, A [3 ]
机构
[1] UCL Royal Free & Univ Coll, Sch Med, Dept Hematol, London NW3 2PF, England
[2] Univ Hosp, Karolinska Inst Huddinge, Dept Med, Div Hematol, SE-14186 Stockholm, Sweden
[3] Novum, Ctr Biotechnol, SE-14157 Huddinge, Sweden
[4] Huddinge Univ Hosp, Karolinska Inst Huddinge, Dept Lab Med, Div Clin Immunol, SE-14186 Stockholm, Sweden
关键词
ATM mutations; ataxia-telongiectasia; B-cell chronic lymphocytic leukemia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor DNA samples from 56 patients with sporadic B-CLL chronic lymphocytic leukemia (B-CLL) were analyzed for mutations in the ATM gene, using exon scanning single strand conformation polymorphism (SSCP). Fifteen patients (27%) showed a pattern compatible with the presence of a somatic mutation. In only five patients, however, was a mutation possibly associated with the disease status detected, suggesting that ATM mutations make only a minor contribution to the pathogenesis of B-CLL.
引用
收藏
页码:109 / 110
页数:2
相关论文
共 50 条
  • [1] ATM mutations in B-cell chronic lymphocytic leukemia
    Bullrich, F
    Rasio, D
    Kitada, S
    Starostik, P
    Kipps, T
    Keating, M
    Albitar, M
    Reed, JC
    Croce, CM
    CANCER RESEARCH, 1999, 59 (01) : 24 - 27
  • [2] Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
    Schaffner, C
    Stilgenbauer, S
    Rappold, GA
    Döhner, H
    Lichter, P
    BLOOD, 1999, 94 (02) : 748 - 753
  • [3] The ATM gene is deleted in a subgroup of B-cell chronic lymphocytic leukemia.
    Starostik, P
    Manshouri, T
    OBrien, S
    Freireich, E
    Kantarjian, H
    Lerner, S
    Keating, M
    Albitar, M
    BLOOD, 1997, 90 (10) : 396 - 396
  • [4] Alemtuzumab for B-cell chronic lymphocytic leukemia
    Robak, Tadeusz
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (07) : 1033 - 1051
  • [5] Rituximab in B-cell chronic lymphocytic leukemia
    Lin, TS
    Lucas, MS
    Byrd, JC
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 483 - 492
  • [6] Alemtuzumab in B-cell chronic lymphocytic leukemia
    Shapira, I
    Grossbard, ML
    CLINICAL LYMPHOMA, 2004, 4 (04): : 228 - 229
  • [7] Histopathology of B-cell chronic lymphocytic leukemia
    Pileri, SA
    Sabattini, E
    Agostinelli, C
    Bodega, L
    Rossi, M
    Zinzani, PL
    Marafioti, T
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (04) : 807 - +
  • [8] The origin of B-cell chronic lymphocytic leukemia
    Ghia, P
    Caligaris-Cappio, F
    SEMINARS IN ONCOLOGY, 2006, 33 (02) : 150 - 156
  • [9] Chronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia
    Robak, T
    Urbanska-Rys, H
    Smolewski, P
    Wawrzyniak, E
    Korycka, A
    Kordek, R
    Bartkowiak, J
    LEUKEMIA & LYMPHOMA, 2003, 44 (11) : 2001 - 2008
  • [10] Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
    Starostik, P
    Manshouri, T
    O'Brien, S
    Freireich, E
    Kantarjian, H
    Haidar, M
    Lerner, S
    Keating, M
    Albitar, M
    CANCER RESEARCH, 1998, 58 (20) : 4552 - 4557